Reduced- or Half-Dose Rivaroxaban Following Left Atrial Appendage Closure: A Feasible Antithrombotic Therapy in Patients at High Risk of Bleeding?

The optimal antithrombotic strategy after percutaneous left atrial appendage closure (LAAC) has not yet been established. The advisability of administering low-dose direct oral anticoagulation after LAAC to patients at high risk of bleeding is uncertain. Thus, in the present study, we evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiao-Dong, Chen, Qin-Fen, Lin, Fang, Wang, Liangguo, Chen, Yihe, Liang, Dongjie, Huang, Weijian, Xiao, Fangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917793/
https://www.ncbi.nlm.nih.gov/pubmed/36769499
http://dx.doi.org/10.3390/jcm12030847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917793/
https://www.ncbi.nlm.nih.gov/pubmed/36769499
http://dx.doi.org/10.3390/jcm12030847

Ejemplares similares